Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System

BACKGROUND: A licensed vaccine against hepatitis C virus (HCV) has not become available to date. The stability and antigenicity of a targeted synthesized recombinant fusion protein consisting of a truncated core and NS3 (rC/N) of HCV had been predicted. Although safe antigens, recombinant proteins a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Iran Biomed J
Autors principals: Hekmat, Soheila, Sadat, Seyed Mehdi, Aslani, Mohammad Mehdi, Mahdavi, Mehdi, Bolhassani, Azam, Halvaee, Fateme Asgar, Ghahari, Seyed Mohammad Mahdi, Aghasadeghi, Mohammad Reza, Siadat, Seyed Davar
Format: Artigo
Idioma:Inglês
Publicat: Pasteur Institute 2019
Matèries:
Full Length
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6462289/
https://ncbi.nlm.nih.gov/pubmed/30278608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.29252/.23.4.235
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars